The recently launched Cancer Research Communications (CRC) is the latest addition to the AACR’s journal portfolio. The new journal is open access and covers the full spectrum of cancer science and medicine, from basic and translational scientific investigations to early- and late-phase clinical trials, epidemiologic studies, and outcomes research. The journal’s nine sections reflect its broad scope: molecular and cellular biology, tumor biology, immuno-oncology, emerging technologies and data science, therapeutic research and development, precision medicine and biomarkers, clinical research and trials, epidemiology and prevention, and health disparities and outcomes research.
This wide range of topics is represented by the different and complementary fields of expertise of the two Editors-in-Chief, cancer genetics and genomics expert Elaine R. Mardis, PhD, FAACR, of Nationwide Children’s Hospital, and medical oncologist and translational researcher Lillian L. Siu, MD, of the Princess Margaret Cancer Centre.
The editors have identified four major criteria – value, technical quality, reproducibility, and accessibility - for editorial consideration. :
Click here to read the original press release.
